Building Blocks

Versatile small molecule scaffold

Versatile small molecule scaffold

2,4-Dibromo-1,3-oxazole is a nitro compound and an important intermediate in the synthesis of herbicides. It is also used to produce coatings and as a reagent for organic synthesis. The compound can be synthesized by the palladium-catalyzed coupling of phenyl bromides with 2,4-dichloro-1,3-oxazole. 2,4-Dibromo-1,3-oxazole has been shown to have potent horticultural activity against plant diseases caused by anions such as fusarium oxysporum. This compound has a pharmacokinetic profile that is favourable for oral administration in humans. The lysine analogues are converted into picolinic acid and then to 2,4-dibromo-1,3-oxazole in the body. The dialkylamino substituents on the molecule are believed to be responsible

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

7-Chloro-benzo[b]thiophene is a nicotinic acetylcholine receptor antagonist that binds to the receptor and blocks its activation. 7-Chloro-benzo[b]thiophene has been shown to be effective in treating Alzheimer's disease in humans, as well as ameliorating the symptoms of schizophrenia in animals. It has also been shown to bind to acetylcholine receptors with high affinity. This drug is an amide derivative of mercaptoacetic acid and an acetylcholine molecule. 7-Chloro-benzo[b]thiophene binds to the receptor at the site where acetylcholine would normally bind, and blocks its activation by preventing the binding of acetylcholine molecules.

4-(Hydroxymethyl)oxazolidin-2-one is an activated form of oxazolidinones that can react with potassium ions to form a stable, water soluble salt. This reaction is catalyzed by lanthanum ion and the reaction mechanism involves the formation of fatty acid esters. It has been found to be effective in the synthesis of methyl palmitate, which is a fatty acid that can be used as a raw material for biodiesel production. The reaction intermediates are dehydrating and constant, and the metal ion is lanthanum. 4-(Hydroxymethyl)oxazolidin-2-one has impurities such as adiponitrile, acidic impurities, and stereoselective impurities.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

2-Methylsulfonylthiophene is a modulating agent that can inhibit the activity of carbonic anhydrase, adenosine receptors and 5-membered heteroaryl. It has been shown to have affinity for CB1 receptor antagonists and is used to treat cardiovascular diseases. 2-Methylsulfonylthiophene also inhibits the enzymatic activity of anhydrase in the eye, which leads to suppression of intraocular pressure (IOP). The drug also has anti-glaucoma effects by reducing the production of aqueous humour. 2-Methylsulfonylthiophene is used as a dyestuff intermediate and as an organic solvent.

4-chlorotetrahydro-2H-thiopyran 1,1-dioxide is an experimental heterocyclic compound. It has a dipole and a methylcyclohexane ring with an axial orientation. The density of the molecule is 1.499 g/cm3. This compound has conformational energies and substituents that are stable at room temperature. Theory predicts that this compound will have 3 conformers, all of which are energetically favorable, with one being more stable than the others. The energies and conformers are influenced by the steric interactions between substituents and cyclohexanes in the molecule. 4-chlorotetrahydro-2H-thiopyran 1,1-dioxide has no electrostatic interactions because it does not have any electronegative atoms or groups.

Cyclopropyl(3,4-dimethylphenyl)methanone (CPM) is a synthetic cannabinoid that has been shown to have similar effects to the natural cannabinoids found in cannabis. CPM binds to and activates the CB2 receptor, which is found on cells of the immune system, brain, and other organs. It has been studied for its ability to reduce glioma tumor growth in mice by inhibiting glutamate release. The molecular modeling study showed that CPM binds to the receptor with a geometry similar to other CB2 agonists like JWH-133. In addition, CPM inhibits locomotor activity in rats and has been shown to produce some symptoms of anxiety in mice. A receptor knockout study with mice showed that CPM can bind to CB2 receptors without activating them. X-ray diffraction data indicated that CPM is an achiral molecule with an idealized molecular geometry of "s".

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

1-Benzenesulfonyl-piperidine-4-carboxylic acid ethyl ester is an inhibitor of acetylcholinesterase. It is a white solid that can be synthesized in two steps from commercially available starting materials. Inhibition of this enzyme leads to the accumulation of acetylcholine, which causes increased stimulation of nicotinic and muscarinic receptors. This drug has been shown to have IC50 values that are similar to those of the reference inhibitor donepezil. 1-Benzenesulfonyl-piperidine-4-carboxylic acid ethyl ester also interacts with sulfonyl chlorides, butyrylcholinesterase, and other proteins in a manner similar to donepezil. The molecular docking studies suggest that this compound binds competitively with the active site of acetylcholinesterase.